Merion, Inc.

Merion, Inc. provides health and nutritional supplements, and personal care products in the People's Republic of China and the United States. The company offers Noir Naturel, a gentle formula for grey coverage from the first application into hair; natural aphrodisiac supplements, Viwooba (1-3) for men; Lady-S, a female dietary supplement that assists on weight loss; Gold King, a nutritional supplement that provides antioxidant support and liver health; New Power, a nutritional supplement, which supports heart health; Taibao, a nutritional supplement that enhances physical performance and energy metabolism; and ReMage Power, a nutritional supplement that provides anti-aging Nicotinamide adenine dinucleotide support, as well as promotes energy and cell metabolis. It sells its products through merionus.com, as well as to wholesale distributors through phone and electronic communication. The company was formerly known as E-World USA Holding, Inc. and changed its name to Merion, Inc. in June 2017. Merion, Inc. was founded in 2007 and is headquartered in West Covina, California.

Merion, Inc. trades as EWLU on OTC. The company is classified in Consumer Defensive / Packaged Foods and reports in USD.

The current profile places the business in Packaged Foods. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $1.48M of revenue and -$1.20M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Merion, Inc. can be compared against peers such as BAB, Inc., CCA Industries, Inc., Green Globe International, Inc., Glucose Health, Inc., Indofood Agri Resources Ltd., Nepra Foods Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $6,229, beta of -34.99, and return on equity of +100.9%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

EWLU currently shows total debt of $707,408 and beta of -34.99. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.merionus.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.